Across the past 12 months, RedHill Biopharma insiders made no open-market purchases, and sold 44.18Mn shares on the open market with no usable reported price.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Gilead Raday | Chief Operating Officer | 437,970,000 | 0 | 437,970,000 | 100.0% | 06 Oct, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Oct, 2026 | Gilead Raday | Chief Operating Officer | Disposed S | 14,310,000 | $0.00 | $1.43K | 176,910,000 | Direct |
| 01 Oct, 2026 | Gilead Raday | Chief Operating Officer | Acquired M | 27,560,000 | $0.00 | $0 | 131,690,000 | Direct |
| 10 Jul, 2026 | Gilead Raday | Chief Operating Officer | Disposed S | 14,130,000 | $0.00 | $1.41K | 218,780,000 | Direct |
| 10 Jul, 2026 | Gilead Raday | Chief Operating Officer | Acquired M | 28,150,000 | $0.00 | $0 | 104,130,000 | Direct |
| 06 Apr, 2026 | Gilead Raday | Chief Operating Officer | Disposed S | 15,740,000 | $0.00 | $1.57K | 261,060,000 | Direct |
| 06 Apr, 2026 | Gilead Raday | Chief Operating Officer | Acquired M | 30,780,000 | $0.00 | $0 | 76,150,000 | Direct |